Clinical Trial Update: An Investigational Study of MK0928 in Adult Outpatients With Insomnia (0928-014)(COMPLETED) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating MK0928 in adult outpatients with insomnia has completed, sponsored by H. Lundbeck A/S.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia

Drugs mentioned

• MK0928

Snippet

Sponsor: H. Lundbeck A/S | Conditions: Insomnia | Phase 3 | Status: COMPLETED